SARS-CoV-2 3CLpro-IN-5
SARS-CoV-2 3CLpro-IN-5 is a covalent inhibitor of 3C-like protease (3CLpro). SARS-CoV-2 3CLpro-IN-5 has inhibitory activity for 3CLpro with an IC50 value of 3.8 nM. SARS-CoV-2 3CLpro-IN-5 has 9.0% oral bioavailability (BA). SARS-CoV-2 3CLpro-IN-5 can be used for the research of coronavirus disease 2019 (COVID-19).
For research use only. We do not sell to patients.
- CAS No.: 2913186-57-7
- Formula: C22H26ClF2N5O4
- Molecular Weight:497.92
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
IC50: 3.8 nM (3CLpro)[1].
EC50 for SARS-CoV-2 strains: 13.8 nM (α), 7.57 nM (δ), 9.01 nM (Om BA.1) and 17.1 nM (Om BA.2) [1].
EC50: 59.3 nM (SARS-CoV in 293TAT cells); 4.72 nM (MERS-CoV in 293TDPP4 cells); 1.67 nM (HCoV-OC43 in 293TAT cells)[1].
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK-293T | CC50 |
>50000 nM
Compound: 8a; YH-6
|
Cytotoxicity against HEK293T cells transfected with ACE2 and TMPRSS2 assessed as reduction in cell viability
Cytotoxicity against HEK293T cells transfected with ACE2 and TMPRSS2 assessed as reduction in cell viability
|
[PMID: 36229406] |
| Vero C1008 | CC50 |
>50000 nM
Compound: 8a; YH-6
|
Cytotoxicity against African green monkey Vero E6 cells transfected with TMPRSS2 assessed as reduction in cell viability
Cytotoxicity against African green monkey Vero E6 cells transfected with TMPRSS2 assessed as reduction in cell viability
|
[PMID: 36229406] |
SARS-CoV-2 3CLpro-IN-5 has inhibitory activity for 3CLpro with an IC50 value of 3.8 nM[1].
SARS-CoV-2 3CLpro-IN-5 has antiviral activity in 293TAT cells againsts various SARS-CoV-2 strains α, δ, Om BA.1 and Om BA.2 with EC50 values of 13.8 nM, 7.57 nM, 9.01 nM and 17.1 nM, respectively[1].
SARS-CoV-2 3CLpro-IN-5 has antiviral activity against various coronaviruses SARS-CoV (293TAT cells), MERS-CoV (293TDPP4 cells) and HCoV-OC43 (293TAT cells) with EC50 values of 59.3 nM, 4.72 nM and 1.67 nM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:mice[1]
-
Dosage:10, 100 mg/kg
-
Administration:oral (100 mg/kg) and intravenous (10 mg/kg) administration
-
Result:Showed the plasma concentration was 15.2 μM after 1 h and decreased to 0.40 μM over 6 h after oral administration (100 mg/kg) .
Showed the plasma concentration reached 9.3 μM after 1 h and decreased to 0.33 μM after 6 h in intravenous administration (10 mg/kg) .
Had approximately 9.0% estimated bioavailability (BA).
Chemical Information
-
CAS No. 2913186-57-7
-
Molecular Weight 497.92
-
Formula C22H26ClF2N5O4
-
SMILES
FC1=CC=CC2=C1C=C(C(N[C@H](C(NN(C([C@@](F)([H])Cl)=O)C[C@H]3C(NCC3)=O)=O)CC(C)C)=O)N2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
SARS-CoV-2 3CLpro-IN-5 Related Classifications
HY-151535 Related Classifications
Powered by Bioz